top of page

RESPONSE_TO_mGrC

Last Updated

Current

node_web_buttons_proteindomain copy 2.png
node_web_buttons_proteindomain copy 2.png

Description

Clinical or preclinical studies testing for the ability of a variant to induce sensitivity to a given treatment in a specific disease context, where patient populations or preclinical samples without the variant may be used as controls. (Primary sensitizing mutation; CIViC)

Properties

  • clin_sig - Clinical significance from CIViC. Download details.

  • disease - List of the disesase ontology names

  • disease_id - List of the numerical part of the disesase ontology ids

  • pubmed - List of references (pubmed ids)

  • sourceCIViC

  • tier - Evidence level: B (clinical), C (case study), and D (preclinical) CIViC

  • url - List of CIViC urls

  • variant - List of variants

Updates

V7        460 edges

V6        596 edges

V5        493 edges

V4        525 edges

V3        524 edges

V2        524 edges

303 Twin Dolphin Drive, 6th Floor

Redwood City, California, USA, 94065

+1 (415) 570-4447

©2025 Mate Bioservices Inc.

Follow Us On:

  • LinkedIn
  • Twitter

User Login:

bottom of page